Moderna, Inc. (MRNA.MX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Stephane Bancel | CEO & Director | 89.6M | -- | 1973 |
| Dr. Stephen Hoge M.D. | President | 49.98M | -- | 1976 |
| Mr. James M. Mock | Chief Financial Officer | 28.5M | -- | 1977 |
| Ms. Shannon Thyme Klinger J.D. | Chief Legal Officer & Corporate Secretary | 31.57M | -- | 1971 |
| Dr. Jerh Collins Ph.D. | Chief Technical Operations & Quality Officer | -- | -- | 1967 |
| Ms. Lavina Talukdar CFA | Senior VP & Head of Investor Relations | -- | -- | -- |
| Ms. Colleen Hussey | Senior Director of Corporate Communications | -- | -- | -- |
| Ms. Tracey Franklin | Chief People & Digital Technology Officer | -- | -- | 1980 |
| Dr. Melanie Ivarsson M.B.A., Ph.D. | Chief Development Officer | -- | -- | -- |
| Mr. Dave Johnson | Chief Data & AI Officer | -- | -- | -- |
Moderna, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5,800
Description
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Corporate Governance
Upcoming Events
May 1, 2025 at 12:30 PM UTC
Moderna, Inc. Earnings Date
Recent Events
Recent Events Information Not Available